Get notified when ENSC files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsEnsysce Biosciences COO Jeffrey Millard resigns effective July 10, 2026
Filed July 15, 2026 · Period ending July 15, 2026 · ~1 min read
Key Changes
-
medium
Chief Operating Officer Jeffrey Millard resigned effective July 10, 2026; no reason disclosed and no successor named.
Item 5.02 — Departure of Directors or Certain Officers; Election of Directors; Compensation verify on EDGAR →
This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (NKE 10-K) is open in full — no account needed.
Partner
Trade ENSC commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jul 15, 2026 · How we verify